Key Facts
- Authority: Union Ministry of Health and Family Welfare
- Legal Framework: Drugs and Cosmetics Act, 1940
- Amendment: Rule 43A of the Drugs Rules, 1945
- Previous Entry Points: 41 (road, rail, sea, and air)
- New Total: 42 approved entry points
- Advisory Body: Drugs Technical Advisory Board (DTAB)
Background
The Navi Mumbai Airport, recently inaugurated, has been designated as an authorized entry point for importing drugs into India. This decision was made after consultation with the Drugs Technical Advisory Board (DTAB), which is a statutory body under the Drugs and Cosmetics Act, 1940.
About DTAB
The Drugs Technical Advisory Board:
- Established under: Drugs and Cosmetics Act, 1940
- Nature: Statutory body
- Function: Advises central and state governments on technical matters related to drugs and cosmetics regulation
Significance
For Pharmaceutical Trade
- Enhanced Logistics: Enables smoother and faster movement of pharmaceutical consignments
- Supply Chain Flexibility: Importers gain an additional route, reducing dependence on existing entry points
- Trade Facilitation: Improves efficiency of importing medicines into India
For Governance and Policy
- Ease of Doing Business: Streamlines the drug import process
- Regulatory Oversight: Maintains effective regulatory control over imported drugs
- Infrastructure Utilization: Optimizes use of new aviation infrastructure
Legal Provisions
Drugs and Cosmetics Act, 1940
- Primary legislation governing drugs and cosmetics in India
- Empowers central government to regulate import, manufacture, distribution, and sale of drugs
Drugs Rules, 1945
- Rule 43A specifically deals with entry points for drug imports
- Amendment designates Navi Mumbai Airport as authorized entry point
Impact on Healthcare Sector
The new entry point is expected to:
- Reduce bottlenecks in pharmaceutical supply chain
- Enable faster delivery of essential medicines
- Support pharmaceutical industry's import operations
- Strengthen India's position in global pharmaceutical trade
Relevance for UPSC
This topic intersects with multiple areas:
- GS Paper 2: Government policies, health governance, regulatory frameworks
- GS Paper 3: Infrastructure development, Ease of Doing Business, trade facilitation
- Prelims: Factual questions on DTAB, entry points, legal provisions
- Mains: Analytical questions on pharmaceutical regulation and trade policy